Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Recruiting · NCT01258231 · Observational (researchers observe without assigning treatment) · Lead sponsor: Brigham and Women's Hospital
View the official record on ClinicalTrials.gov →What this trial is about
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.
Who can take part
Age range
20 Years to 90 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Undergoing heart surgery
- Willing to provide consent
Exclusion criteria
- Enrolled in a concurrent drug or device trial that precludes concurrent enrollment
Where it is running
6 locations listed across 2 US states.
- Brigham and Women's Hospital - Boston, Massachusetts, United States
- Brigham and Women's Hospital - Boston, Massachusetts, United States
- UT Southwestern Medical Center - Dallas, Texas, United States
- UT Southwestern Medical Center - Dallas, Texas, United States
- Department Texas Heart Institute at St. Luke's Episcopal Hospital - Houston, Texas, United States
- Department Texas Heart Institute at St. Luke's Episcopal Hospital - Houston, Texas, United States